A highly sensitive ultra performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) technique for quantitation of protein free and bound efavirenz (EFV) in human seminal and blood plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 31, 2010, Pages 3217-3224

  Avery, Lindsay B ^a   Parsons, Teresa L ^a   Meyers, David J ^a   Hubbard, Walter C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood plasma; Efavirenz; Electrospray ionization (ESI); HIV AIDS; Seminal plasma; UPLC MS MS

Indexed keywords

BLOOD PLASMA; EFAVIRENZ; ELECTROSPRAYS; HIV/AIDS; SEMINAL PLASMA; UPLC-MS/MS;

DISEASES; ELECTROSPRAY IONIZATION; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; PARTICLE DETECTORS; PLASMAS; POSITIVE IONS; SPECTROMETRY;

BLOOD;

EFAVIRENZ;

ACCURACY; ARTICLE; BIOLOGICAL MONITORING; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORINATION; HUMAN; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SEMINAL PLASMA; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTI-HIV AGENTS; BENZOXAZINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; LEAST-SQUARES ANALYSIS; REPRODUCIBILITY OF RESULTS; SEMEN; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 78449294619     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.09.011     Document Type: Article

References (18)

1. Royce R., Seña A., Cates W., Cohen M. N. Engl. J. Med. 1997, 336:1072.
2. Cao Y.J., Hendrix C. Clin. Pharmacol. Ther. 2008, 83:401.
3. Kashuba A., Dyer J., Kramer L., Raasch R., Eron J., Cohen M. J. Antimicrob. Chemother. 1999, 43:1817.
4. Boffito M., Back D., Blaschke T., Rowland M., Bertz R., Gerber J., Miller V. AIDS Res. Hum. Retroviruses 2003, 19:825.
5. Reddy Y., Gotzkowsky K., Eron J., Kim J., Fiske W., Fiscus S., Petch L., Cohen M., Kashuba A. J. Infect. Dis. 2002, 186:1339.
6. Cao Y.J., Ndovi T., Parsons T., Guidos A., Caffo B., Hendrix C. Clin. Pharmacol. Ther. 2008, 83:848.
7. Y.J. Cao, Doctoral Thesis (Graduate Training Program in Clinical Investigation, Johns Hopkins Univ., Baltimore, MD, 2007).
8. Coombs R., Speck C., Hughes J., Lee W., Sampoleo R., Ross S. J. Infect. Dis. 1998, 177:320.
9. Ramachandran G., Hemanth Kumar A., Swaminathan S., Venkatesan P., Greenblatt D. J. Chromatogr. B 2006, 835:131.
10. Martina J., Deslandesa G., Dailly E., Renauda C., Reliquet V., Raffic F., Jolliet P. J. Chromatogr. B 2009, 877:3072.
11. Mogatle S., Kanfer I. J. Pharm. Biomed. Anal. 2009, 49:1308.
12. Quaranta S., Woloch C., Paccou A., Giocanti M., Solas C., Lacarelle B. Ther. Drug. Monit. 2009, 31:695.
13. Pierce M.E., Parsons R.L., Radesca L.A., Lo Y.S., Silverman S., Moore J.R., Islam Q., Choudhury A., Fortunak J.M.D., Nguyen D., Luo C., Morgan S.J., Davis W.P., Confalone P.N., Chen C., Tillyer R.D., Frey L., Tan L., Xu F., Zhao D., Thompson A.S., Corley E.G., Grabowski E.J.J., Reamer R., Reider P.J. J. Org. Chem. 1998, 63:8536.
14. Radesca L.A., Lo Y.S., Moore J.R., Pierce M.E. Synth. Commun. 1997, 27:4373.
15. Cocuzza A.J., Chidester D.R., Cordova B.C., Klabe R.M., Jeffery S., Diamond S., Weigelt C.A., Ko S.S., Bacheler L.T., Erickson-Viitanen S., Rodgers J.D. Bioorg. Med. Chem. Lett. 2001, 11:1389.
16. Patel M., McHugh R.J., Cordova B.C., Klabe R.M., Erickson-Viitanen S., Trainor G.L., Ko S.S. Bioorg. Med. Chem. Lett. 1999, 9:3221.
17. Sriram D., Banerjee D., Yogeeswari P. J. Enzyme Inhib. Med. Chem. 2009, 24:1.
18. U.S. Department of Health and Human Services, FDA Guidance for Industry and Bioanalytical Method Validation, 2001.